Goldman Sachs’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Buy |
275,978
+96,343
| +54% | +$53.8K | ﹤0.01% | 4794 |
|
|
2025
Q1 | $85.5K | Buy |
179,635
+38,052
| +27% | +$18.1K | ﹤0.01% | 4851 |
|
|
2024
Q4 | $143K | Buy |
141,583
+33,463
| +31% | +$33.8K | ﹤0.01% | 4716 |
|
|
2024
Q3 | $185K | Buy |
108,120
+37,314
| +53% | +$63.8K | ﹤0.01% | 4514 |
|
|
2024
Q2 | $181K | Buy |
70,806
+31,523
| +80% | +$80.4K | ﹤0.01% | 4394 |
|
|
2024
Q1 | $164K | Sell |
39,283
-5,342
| -12% | -$22.3K | ﹤0.01% | 4376 |
|
|
2023
Q4 | $148K | Sell |
44,625
-3,653
| -8% | -$12.1K | ﹤0.01% | 4398 |
|
|
2023
Q3 | $96.6K | Buy |
48,278
+5,067
| +12% | +$10.1K | ﹤0.01% | 4396 |
|
|
2023
Q2 | $137K | Sell |
43,211
-9,757
| -18% | -$30.8K | ﹤0.01% | 4506 |
|
|
2023
Q1 | $184K | Buy |
52,968
+22,818
| +76% | +$79.2K | ﹤0.01% | 4547 |
|
|
2022
Q4 | $155K | Buy |
30,150
+9,094
| +43% | +$46.7K | ﹤0.01% | 4577 |
|
|
2022
Q3 | $208K | Sell |
21,056
-4,712
| -18% | -$46.5K | ﹤0.01% | 4703 |
|
|
2022
Q2 | $216K | Buy |
25,768
+5,022
| +24% | +$42.1K | ﹤0.01% | 4871 |
|
|
2022
Q1 | $261K | Buy |
20,746
+2,091
| +11% | +$26.3K | ﹤0.01% | 4953 |
|
|
2021
Q4 | $296K | Buy |
+18,655
| New | +$296K | ﹤0.01% | 4787 |
|
|
2021
Q3 | – | Sell |
-52,808
| Closed | -$1.55M | – | 5432 |
|
|
2021
Q2 | $1.55M | Buy |
+52,808
| New | +$1.55M | ﹤0.01% | 3702 |
|